New business model for antibiotics
Revenues for pharmaceutical companies need to be delinked from sales of antibiotics to avoid their over-use and avert a public health crisis, according to a new report from the Centre on Global Health Security, Chatham House. The main recommendations of the report are: A new business model needs to be developed in which the return on […]
New business model for antibiotics Read More »